The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.
There are four major factors that are impacting the value creation in pharmaceutical industry:
Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases
Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.
The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.
Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.
Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.
Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.
Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.
Growth in Emerging Economies
The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.
Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.
There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.
Treprostinil is a synthetic prostacyclin prescribed for the treatment of pulmonary arterial hypertension. Treprostinil works as a vasodilator lowering the blood pressure in the pulmonary artery leading from heart to lungs and is known to improve the ability to exercis... View more
Iloprost is a drug used for treating diseases such as pulmonary arterial hypertension, scleroderma, Raynaud syndrome, and other conditions where constriction in blood vessels and improper blood flow in tissues is found. The trade name of the drug is Ventavis or Ilomed... View more
The global surface plasmon resonance market is estimated to be valued at US$ 976.1 million in 2023 and is expected to exhibit a CAGR of 6.5% during the forecast period (2023-2030). ... View more
North America toxicology laboratories market is estimated to be valued at US$ 271.0 Million in 2023, exhibiting a CAGR of 4.1% during the forecast period (2023-2030). ... View more
Global factor VIII deficiency treatment market is estimated to be valued at US$ 2,520.0 million in 2023 and is expected to exhibit a CAGR of 5.1% during the forecast period (2023... View more
Middle East and Turkey Hemophilia Treatment Marketis estimated to be valued at US$ 756.0 Million in 2023, exhibiting a CAGR of 4.5% during the forecast period (2023-2030). ... View more
Global Peptic Ulcer Drugs market is estimated to be valued at US$ 34,339.4 million in 2023 and is expected to exhibit a CAGR of 4.1% during the forecast period (2023... View more
Medical meals are custom-made liquid solutions created with the sole purpose of curing persons suffering from various illnesses. Professionals provide the designed meal to people suffering from various illnesses. It is a specially prepared diet that provides patients ... View more
The process of combining, blending, or changing substances to make a treatment specific to the requirements of a particular patient is known as drug compounding. Combining two or more medications is referred to as compounding. In dermatology, compounded drugs are freq... View more
Increasing number of people suffering from venous thromboembolism (VTE) is subsequently resulting in rising demand for heparin. For instance, according to the American Heart Association Inc. (AHA), the study published in Burden of Thrombosis in 2016 reports that major... View more
Artificially produced reproductive hormones are used for various medical reproductive conditions. There are few brands available in market which includes, Cenestin, Ogen, Femtrace, Menest (Pro), and Divigel. The reproductive hormones play major role in fertility and s... View more
Poliomyelitis (polio) is viral infectious disease that mostly occurs in children of age group below 6 years. The polio virus transmits through contact with an infected person primarily through the fecal or oral route and sometimes with contaminated water and food. It ... View more
A contract research organization (CRO) is a service provider organization that offers various drug developmental and clinical data management services supporting pharmaceutical and biotechnology industries engaged in clinical trials, in the form of outsourced pharmace... View more
Cytotoxic drugs are high potent drug products that has application in the treatment of cancer. Cytotoxic drugs contract manufacturing are the services that are utilized by the pharmaceutical, biotech manufacturing companies, in order to treat chronic diseases such as ... View more
Thrombocytopenia is a disorder in which a patient has low level of platelets in the blood. The major causes of thrombocytopenia are inefficient production of platelets, platelet splenic sequestration, and accelerative destruction of platelets. Thrombocytopenia can be ... View more
Netherlands Compounding Pharmacies Market — Insights A pharmacy that is operated by a licensed pharmacist, licensed physician or a person under the guidance of a licensed pharmacist is called compoundin... View more
US Cannabis Testing Services Market – Insights Development of therapies derived from cannabis and its components has been increasing in the recent past. Moreover, there has been extensive research and d... View more
A patient who cannot be treated with an Food and Drug Administration (FDA)-approved drug, such as one who has a dye allergy and needs a medication to be made without it, or a patient who is elderly or a child who is unable to swallow a tablet or capsule and needs a me... View more
Italy Peptide Receptor Radionuclide Therapy (PRRT) Market – Insights The market opportunities for key players to enter into this market are high owing to less competition and increasing demand for pepti... View more
Gout is the condition that is characterized by formation of excess of uric acid in body tissues that results in the formation of crystals of monosodium urate. Symptoms of gout includes intense pain, swelling, and stiffness in the joints. The progression stages of gout... View more